BevCanna Announces Amendment to Health Canada Research License, Allowing Sensory Evaluations Within Product Development Trials
Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc.(CNSX: BEV, OTCMKTS: BVNNF)announces today that it has been granted an amendment to its Health Canada-authorized Cannabis Research License to include sensory evaluations of cannabis beverages in its product development trials. This update to the License will allow BevCanna to conduct on-site human assessments of the taste, smell, feel and visual appeal of its products in development.
These new product trial capabilities, unique in the Canadian cannabis beverage market, will open up significant opportunities in the formulation and refinement of BevCanna’s products and those of its white-label clients. The ability to assess critical success factors of new products will enable BevCanna to test, evaluate and refine beverage formulations based on additional consumer appeal factors, increasing and accelerating the commercial success of new products.
Being able to test the taste, smell, feel and visual appeal of our products gives us a significant advantage in being able to develop the innovative, appealing beverages that BevCanna is known for in the cannabis beverage market. This advancement further cements our position as the premier specialty cannabis beverage manufacturer in Canada.Melise Panetta, President of BevCanna
The product trials will take place on-site at BevCanna’s manufacturing facility near Osoyoos, British Columbia.
The Company also announces that it has published an updated corporate presentation that may be viewed at: https://bevcanna.s3.us-east-2.amazonaws.com/BEV+x+Embark+-+M%26A+Deck+-+Final.pdf
To view the original press release in its entirety click here